Therapeutic potential of IL-27 in multiple sclerosis?

Author： Fitzgerald Denise C   Rostami Abdolmohamad  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.9, Iss.2, 2009-02, pp. : 149-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alemtuzumab and multiple sclerosis: therapeutic application

By Alireza Minagar   J Steven Alexander   Mohammad Ali Sahraian   Robert Zivadinov  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of targeting IL-1 and IL-18 in inflammation

By Braddock Martin   Quinn Anthony   Canvin Jan  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 6, 2004-06 ,pp. : 847-860

Informa Healthcare

Access to resources Recommend Favorite

Linkage and association of proinflammatory cytokines genes IL-6, IFNG and TNF with multiple sclerosis

By Makarycheva O.   Tsareva E.   Sudomoina M.   Kulakova O.   Bykova O.   Gol'tsova N.   Kuzenkova L.   Boiko A.   Favorova O.  

Molecular Biology, Vol. 44, Iss. 5, 2010-10 ,pp. : 728-733

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Tovaxin for multiple sclerosis

By Rivera Victor M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite